Insider · CIK 0001735944

Kewalramani Reshma

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001735944

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−400 sh	$479.75	−$192K	137,878
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−120 sh	$481.50	−$57.8K	137,758
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−240 sh	$482.84	−$116K	137,518
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−2,510 sh	$487.13	−$1.22M	135,008
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−3,278 sh	$488.27	−$1.6M	131,730
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−460 sh	$489.32	−$225K	131,270
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−2,725 sh	$490.54	−$1.34M	128,545
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−949 sh	$491.30	−$466K	127,596
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−2,520 sh	$493.29	−$1.24M	125,076
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−3,498 sh	$494.33	−$1.73M	121,578
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−15.6K sh	$495.38	−$7.72M	105,998
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−5,995 sh	$496.16	−$2.97M	100,003
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−1,725 sh	$496.95	−$857K	98,278
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−4,981 sh	$485.11	−$2.42M	138,278
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+16.3K sh	—	—	149,813
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−6,554 sh	$483.75	−$3.17M	143,259
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−13K sh	$487.76	−$6.36M	133,487
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−8,297 sh	$468.41	−$3.89M	146,528
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+27K sh	—	—	142,940
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+11.9K sh	—	—	154,825
2025-08-06	VRTXVERTEX PHARMACEUTICALS INC / MAP Purchase	Director, CEO & President	PPurchase	+4,290 sh	$389.08	+$1.67M	110,258
2025-08-06	VRTXVERTEX PHARMACEUTICALS INC / MAP Purchase	Director, CEO & President	PPurchase	+5,710 sh	$389.95	+$2.23M	115,968
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−14.1K sh	$479.61	−$6.75M	105,915
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−9,386 sh	$483.28	−$4.54M	119,994
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−6,553 sh	$463.46	−$3.04M	129,380
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+19K sh	—	—	135,933
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−8,300 sh	$467.98	−$3.88M	116,918
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+29.1K sh	—	—	104,890
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+20.3K sh	—	—	125,218
2024-11-08	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−15.2K sh	$515.00	−$7.83M	75,772
2024-07-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−15.2K sh	$505.00	−$7.68M	90,970
2024-07-22	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−15.2K sh	$497.00	−$7.56M	106,172
2024-06-12	DNAGinkgo Bioworks Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+105K sh	—	—	186,002
2024-06-12	DNAGinkgo Bioworks Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−105K sh	—	—	0
2024-05-24	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+1,565 sh	$187.53	+$293K	122,939
2024-05-24	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−1,565 sh	$457.00	−$715K	121,374
2024-05-24	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−1,565 sh	—	—	0
2024-05-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−15.2K sh	$447.00	−$6.8M	121,374
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−9,386 sh	$431.79	−$4.05M	136,507
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−7,019 sh	$420.58	−$2.95M	145,893
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−9,359 sh	$424.01	−$3.97M	152,912
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	Director, CEO & President	FTax Payment	−8,255 sh	$422.74	−$3.49M	162,271
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+20.3K sh	—	—	170,526
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+14.5K sh	—	—	123,227
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director, CEO & President	AAward	+27K sh	—	—	150,199
2023-12-15	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+3,058 sh	$155.57	+$476K	111,769
2023-12-15	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+14.1K sh	$187.53	+$2.64M	125,846
2023-12-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director, CEO & President	SSale	−17.1K sh	$407.00	−$6.97M	108,711
2023-12-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−3,058 sh	—	—	0
2023-12-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−14.1K sh	—	—	1,565

Recent filings

Accepted (ET)
Mar 34
Kewalramani Reshma0000875320-26-000129
SEC(opens sec.gov)
Feb 264
Kewalramani Reshma0000875320-26-000114
SEC(opens sec.gov)
Feb 194
Kewalramani Reshma0000875320-26-000090
SEC(opens sec.gov)
Feb 184
Kewalramani Reshma0000875320-26-000070
SEC(opens sec.gov)
Feb 124
Kewalramani Reshma0000875320-26-000046
SEC(opens sec.gov)
Jan 264
Kewalramani Reshma0000875320-26-000018
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210